In the first of a series on the scientific and investment implications of the coronavirus pandemic, Global Life Sciences Portfolio Manager Andy Acker and Biotech Analyst Agustin Mohedas discuss recent developments to curtail the spread of COVID-19 and how they view the timeline for an eventual return to normalcy in the global economy.

Tune in to our Professional Development Series: Coaching Calls for conversations that motivate, inspire and improve your everyday.

Janus Henderson Radio

Explore our podcasts featuring professional development coaching, retirement perspectives and market insights.